// App-Quantinova.ai

3842 : Design and engineering of TRAIL fusion proteins for cancer therapy

Researchers

Presenter

  • Eric M. Tam

Principal Investigators

  • Hannah Hudson

  • Tamara Dake

  • Sara Ghassemifar

  • Andreas Raue

  • Yasmin Hashambhoy-Ramsay

  • Stephen L. Sazinsky

  • Anahita Daruwalla

  • Neeraj Kohli

  • Lihui Xu

  • Charlotte F. Mc Donagh

  • Birgit Schoeberl

  • Diana H. Chai

Medical Centers

  • Merrimack Pharmaceuticals, Cambridge, MA

  • University of North Carolina, Chapel Hill, NC

  • Jounce Therapeutics, Cambridge, MA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • TNF superfamily member 10

Drug/Treatment

  • mapatumumab

  • Drozitumab

Outcome

  • N/A

Study Design

  • Pharmacokinetics

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved